GC Genome Corporation (KOSDAQ:340450)

GC Genome Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	175,016	161,298	-	-	-	-
Enterprise Value	138,917	124,035	-	-	-	-
Last Close Price	7400.00	6820.00	-	-	-	-
PE Ratio	40.00	39.88	-	-	-	-
PS Ratio	5.55	5.12	-	-	-	-
PB Ratio	2.24	2.06	-	-	-	-
P/TBV Ratio	2.25	2.08	-	-	-	-
P/FCF Ratio	177.58	163.66	-	-	-	-
P/OCF Ratio	134.94	124.37	-	-	-	-
EV/Sales Ratio	4.41	3.93	-	-	-	-
EV/EBITDA Ratio	29.83	30.23	-	-	-	-
EV/EBIT Ratio	77.65	100.38	-	-	-	-
EV/FCF Ratio	140.95	125.85	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.14	0.47	0.40	0.74
Debt / EBITDA Ratio	0.98	0.98	2.35	3.18	-	-
Debt / FCF Ratio	4.08	4.08	94.54	-	-	-
Net Debt / Equity Ratio	-0.46	-0.46	-0.06	0.13	-0.26	-0.61
Net Debt / EBITDA Ratio	-8.80	-8.80	-0.93	0.84	16.39	224.25
Net Debt / FCF Ratio	-36.63	-36.63	-37.60	-0.77	1.25	3.96
Asset Turnover	0.50	0.50	0.62	0.60	0.53	0.44
Inventory Turnover	10.51	10.51	11.96	11.56	14.85	-
Quick Ratio	17.67	17.67	3.74	1.00	2.13	6.26
Current Ratio	18.59	18.59	4.27	1.12	2.32	6.42
Return on Equity (ROE)	7.26%	7.26%	-4.32%	-2.13%	-16.52%	1.56%
Return on Assets (ROA)	1.23%	1.23%	-1.85%	0.22%	-4.43%	-3.13%
Return on Invested Capital (ROIC)	3.01%	3.28%	-4.15%	0.67%	-24.07%	-34.01%
Return on Capital Employed (ROCE)	1.50%	1.50%	-3.30%	0.50%	-8.40%	-5.60%
Earnings Yield	2.31%	2.51%	-	-	-	-
FCF Yield	0.56%	0.61%	-	-	-	-
Buyback Yield / Dilution	-20.01%	-20.01%	0.66%	-13.53%	-0.97%	10.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.